Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II/III Randomized Controlled Trial of Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin for Recurrent Clostridium Difficile Infection (CDI)

NCT01226992 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01226992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01226992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II/III Randomized Controlled Trial of Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin for Recurrent Clostridium Difficile Infection (CDI)
Lead sponsor
University Health Network, Toronto
Phase
Phase 2/3
Overall status
Terminated
Start date
October 31, 2010
Completion date
October 31, 2014
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

laboratory confirmed clostridium difficile infection, recurrent clostridium difficile infection